Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Evaluation of Proteasome as a Marker of Hepatocellular Carcinoma in Cirrhotic Patients Following Curative Treatment

The recruitment status of this study is unknown because the information has not been verified recently.
Verified April 2013 by University Hospital, Montpellier.
Recruitment status was  Active, not recruiting
Information provided by (Responsible Party):
University Hospital, Montpellier Identifier:
First received: December 12, 2011
Last updated: April 22, 2015
Last verified: April 2013
No Study Results Posted on for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: March 2016
  Primary Completion Date: March 2014 (Final data collection date for primary outcome measure)